HR Execs on the Move

Stellaris Health Network Inc

www.stellarishealth.org

 
Stellaris Health Network Inc is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in White Plains, NY. To find more information about Stellaris Health Network Inc, please visit www.stellarishealth.org
  • Number of Employees: 25-100
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

Novus Anesthesia Partners

Novus Anesthesia Partners is a company that provides anesthesia management services for small to medium size hospitals, solving financial and operational challenges in the delivery of anesthesia services.

Assured Space Access

Assured Space Access Technologies is a company that provides engineering services to the Aerospace Industry, with specific focus on defense space systems. They specialize in Satellite System Design, Assembly, Integration and Test Engineering, Analysis,...

InterPro Transcription Solutions.

InterPro Transcription Solutions. is a Sun City, AZ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Nevada Health Centers

Nevada Health Centers, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Nevada Health Centers, Inc. is based in Carson City, NV. You can find more information on Nevada Health Centers, Inc. at www.nvrhc.org

Xenon Pharmateuticals

Xenon Pharmaceuticals (NASDAQ:XENE) – a biopharmaceutical company with operations in Vancouver, BC, Canada and Boston, MA, U.S.A. – is committed to delivering innovative medicines to provide a brighter future for patients suffering from neurological disorders. At Xenon, we are advancing an exciting pipeline of neurology-focused therapies, with a particular emphasis on novel treatments for both adult and pediatric patients with epilepsy. XEN496 is currently being evaluated in the Phase 3 “EPIK” clinical trial in young patients with KCNQ2-DEE, a rare and severe form of childhood epilepsy. Late-stage development plans are also underway for our XEN1101 program, building upon the compelling data from the Phase 2b “X-TOLE” study in adult patients with focal epilepsy. We are also proud of the leading-edge science coming out of our discovery labs, with many early-stage research programs underway. In addition to Xenon`s proprietary programs, we have ongoing collaborations with our valued pharmaceutical partners. With a healthy balance sheet to support our growth plans, we continue to build a fully-integrated, premier neuroscience company with strong discovery, development, and commercial operations. Our employees are smart, passionate, dedicated, and driven by their incredibly important work to discover, develop, and deliver new medicines for patients in need. Building and maintaining a respectful, collaborative, inclusive, and productive culture is a priority for us. We are looking for great people who thrive in a fast-paced, dynamic work environment to join our team during this transformative time for Xenon.